key: cord-0960364-2ftw85xw
authors: Yang, Yi; Shang, Weilong; Rao, Xiancai
title: Facing the COVID‐19 outbreak: What should we know and what could we do?
date: 2020-03-05
journal: J Med Virol
DOI: 10.1002/jmv.25720
sha: 39a6db38022dcd1700202c2a7a3732d758f7f284
doc_id: 960364
cord_uid: 2ftw85xw

A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan, Hubei Province in China in December 2019 and caused a serious type of pneumonia called coronavirus disease 2019 or COVID-19. This epidemic quickly spread across China and extended to more than 20 other countries. This commentary discusses the reasons for the fast spread of SARS-CoV-2 in three aspects: the infectious sources, including the biological nature of the virus; the susceptible population; and the transmission routes. The current situations and suggestions regarding the control of the disease are summarized. This article is protected by copyright. All rights reserved.

in Wuhan City, Hubei Province in China and caused atypical pneumonia called coronavirus disease 2019 (COVID-19). 1 The disease is characterized by fever, cough, fatigue, and ground-glass opacity on chest tomography. 1, 2 The epidemic began with four confirmed cases on 29 December 2019. 2 The first confirmed case in Tibet was an- The WHO issued a public health emergency of international concern on 30 January 2020.

How could SARS-CoV-2 spread so fast?

In general, the emergence of an infectious disease consists of three vital elements: infectious source, susceptible population, and transmission route. The source of SARS-CoV-2 is complex. Most patients with COVID-19 among the first cluster of pneumonia cases (27 of 41, 65.9%) were exposed to Huanan seafood market, 2 and several wild animals, including bats, snakes, minks, and pangolins, were reported to be the possible reservoir for SARS-CoV-2. [4] [5] [6] Patients are currently the major sources for the COVID-19 outbreak given the increasing number of cases. Mild but infectious cases may also serve as sources and make COVID-19 difficult to control. 7 As the causative agent of COVID-19, SARS-CoV-2 was quickly isolated and its whole genome sequence was submitted to GenBank (accession number MN908947) on 5 January 2020. 8 Bioinformatic analyses have shown that SARS-CoV-2 belongs to the genus of β-coronavirus and shares at least 70% similarity in genetic sequence with SARS-CoV, another kind of β-genus CoV that caused a largescale coronavirus infection in China in 2002. 6 Additionally, SARS-CoV-2 and SARS-CoV may recognize the same receptor, the angiotensin-converting enzyme 2 (ACE2). 6 One important difference is that several key residues on the spike (S) protein of SARS-CoV-2 have changed when compared with SARS-CoV. 5 Wan et al 5 suggested that these mutations may weaken virus-receptor interactions.

Nevertheless, the latest reports argued that SARS-CoV-2 S protein binds ACE2 with a much higher affinity than SARS-CoV S protein does. 9 This may be an important factor contributing to the quick spread of COVID-19. The route of transmission is the third important factor for infectious disease. SARS-CoV-2 is transmitted between humans mainly via aerial droplets and direct contact. 1, 2 The virus is also found in stool specimens of patients, suggesting potential fecal-oral transmission pathway; however, this route requires further investigation. 10 The Wuhan government has pronounced to shut down public transport system since 23 January 2020 to control virus transmission. All other cities in Hubei Province implemented similar policies in the next 3 days. However, SARS-CoV-2 transmission seemed to be not effectively controlled. Only 425 cases were reported before 22 January 2020, yet, the confirmed cases have explosively increased since then. 2 Besides, home quarantine is the best choice for residents, however, the widespread lockdown may inevitably bring a psychological effect; hence, mental health counseling and popularization are recommended. Lastly, we should say that what we have done today is not only to control COVID-19 but, more importantly, to build a security system to prevent similar outbreaks in the future.

http://orcid.org/0000-0002-9905-760X

Clinical characteristics of 2019 novel coronavirus infection in China

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

World Health Organization

Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm

Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS

Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding

What to do next to control the 2019-nCoV epidemic?

A new coronavirus associated with human respiratory disease in China

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

First case of 2019 novel coronavirus in the United States